Menu
GeneBe

rs121434390

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_ModeratePP5_Moderate

The NM_004621.6(TRPC6):​c.335C>A​(p.Pro112Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P112S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

TRPC6
NM_004621.6 missense

Scores

10
5
4

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 10.0
Variant links:
Genes affected
TRPC6 (HGNC:12338): (transient receptor potential cation channel subfamily C member 6) The protein encoded by this gene forms a receptor-activated calcium channel in the cell membrane. The channel is activated by diacylglycerol and is thought to be under the control of a phosphatidylinositol second messenger system. Activation of this channel occurs independently of protein kinase C and is not triggered by low levels of intracellular calcium. Defects in this gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_004621.6
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.923
PP5
Variant 11-101504634-G-T is Pathogenic according to our data. Variant chr11-101504634-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 6151.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TRPC6NM_004621.6 linkuse as main transcriptc.335C>A p.Pro112Gln missense_variant 2/13 ENST00000344327.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TRPC6ENST00000344327.8 linkuse as main transcriptc.335C>A p.Pro112Gln missense_variant 2/131 NM_004621.6 P1Q9Y210-1
TRPC6ENST00000360497.4 linkuse as main transcriptc.335C>A p.Pro112Gln missense_variant 2/121 Q9Y210-3
TRPC6ENST00000348423.8 linkuse as main transcriptc.335C>A p.Pro112Gln missense_variant 2/111 Q9Y210-2
TRPC6ENST00000532133.5 linkuse as main transcriptc.335C>A p.Pro112Gln missense_variant 2/125

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Focal segmental glomerulosclerosis 2 Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteJul 17, 2023Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0101 - Gain of function is a known mechanism of disease in this gene and is associated with glomerulosclerosis, focal segmental, 2 (MIM#603965). Missense variants have been functionally proven to result in increased calcium channel activity (PMID: 15879175, PMID: 32509715). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from proline to glutamine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated ankyrin repeat domain (DECIPHER). (I) 0703 - Other missense variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. One alternative change (p.(Pro112Arg)) was observed as de novo in an individual with sub-nephrotic range proteinuria (PMID: 32509715), and another alternative change (p.(Pro112Leu)) has been reported in an individual with focal segmental glomerulosclerosis (FSGS) and proteinuria, who also had a non-pathogenic variant in the COL4A5 gene (PMID: 31576025). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant has been reported in a single family with FSGS (PMID: 15879175). (SP) 0901 - This variant has strong evidence for segregation with disease. This variant segregated in 20 affected individuals within a single family with FSGS (PMID: 15879175). (SP) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Transfected cells showed increased intracellular calcium, increased angiotensin signalling and protein mislocalization (PMID: 15879175). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Pathogenic, no assertion criteria providedliterature onlyOMIMJun 17, 2005- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
28
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.42
T;.;.;.
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D;D;D;D
M_CAP
Benign
0.034
D
MetaRNN
Pathogenic
0.92
D;D;D;D
MetaSVM
Benign
-0.33
T
MutationAssessor
Benign
0.55
N;.;N;N
MutationTaster
Benign
1.0
A;A;A;A
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-5.0
D;D;D;D
REVEL
Pathogenic
0.66
Sift
Uncertain
0.0020
D;D;D;D
Sift4G
Uncertain
0.013
D;D;D;D
Polyphen
1.0
D;.;D;D
Vest4
0.81
MutPred
0.80
Loss of catalytic residue at P112 (P = 0.096);Loss of catalytic residue at P112 (P = 0.096);Loss of catalytic residue at P112 (P = 0.096);Loss of catalytic residue at P112 (P = 0.096);
MVP
0.86
MPC
0.98
ClinPred
0.99
D
GERP RS
5.9
Varity_R
0.88
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121434390; hg19: chr11-101375365; API